Prenatal parvovirus B19 infection.

Autor: Kagan KO; Department of Obstetrics and Gynaecology, University Hospital Tuebingen, Calwerstrasse 7, 72076, Tuebingen, Germany. KOKagan@gmx.de., Hoopmann M; Department of Obstetrics and Gynaecology, University Hospital Tuebingen, Calwerstrasse 7, 72076, Tuebingen, Germany., Geipel A; Department of Obstetrics and Prenatal Medicine, University Hospital of Bonn, Bonn, Germany., Sonek J; Division of Maternal Fetal Medicine, Boonshoft School of Medicine, Wright State University, Dayton, USA., Enders M; Laboratory Prof. Gisela Enders and Colleagues, Stuttgart, Germany, & German Consulting Laboratory for Parvoviruses, Stuttgart, Germany.

Publikováno v: Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2024 Nov; Vol. 310 (5), pp. 2363-2371. Date of Electronic Publication: 2024 Jul 29.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Infectious parvovirus B19 circulates in the blood coated with active host protease inhibitors.

Autor: Lee, Hyunwook, Assaraf, Ruben, Subramanian, Suriyasri, Goetschius, Dan, Bieri, Jan, DiNunno, Nadia M., Leisi, Remo, Bator, Carol M., Hafenstein, Susan L., Ros, Carlos

Publikováno v: Nature Communications; 11/5/2024, Vol. 15 Issue 1, p1-15, 15p

Risk of human parvovirus B19 infections among school and hospital employees during endemic periods.

Autor: Adler SP, Manganello AA, Koch WC, Hempfling SH, Best AM, Adler, S P, Manganello, A M, Koch, W C, Hempfling, S H, Best, A M

Publikováno v: Journal of Infectious Diseases; 1993, Vol. 168 Issue 2, p361-368, 8p

Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events.

Autor: Marshall BC; Division of Infectious Diseases, Department of Pediatrics, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA. bmarshall@mcvh-vcu.edu, Koch WC

Publikováno v: Paediatric drugs [Paediatr Drugs] 2009; Vol. 11 (5), pp. 309-21.